Dr. Reddy's Laboratories Ltd

RDY Healthcare Drug Manufacturers Specialty & Generic

Dr. Reddy's Laboratories Ltd’s revenue for fiscal 2026 (year ended March 2026) was $3.6 billion, down 6.06% from fiscal 2025.

Revenue
−10.1%
EPS
−36.8%
Free cash flow
−70.5%
Total debt
+14.1%

Quarter to September 2026, against a year earlier

14.86 0.33 +2.27%
Market cap
$12.1B
P/E
44.4×
Fwd P/E
30.7×
Dividend yield
0.00%
F-score
4/9
Altman Z
5.26
Beneish M
−2.59
Dividend safety
74/100
Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22 Mar '23 Mar '24 Mar '25 Mar '26
Piotroski F-Score
5 5 8 7 5 6 8 6 2 4
P/E ratio
36.83 35.22 25.19 24.60 43.04 29.88 17.10 18.30 19.98 25.79
Altman Z-Score
4.33 3.86 5.35 6.30 7.07 6.38 7.87 8.43 5.94 5.26
P/S ratio
3.08 2.46 3.02 2.89 3.93 3.27 3.16 3.67 2.88 3.22
Altman Z″-Score (non-manufacturers)
3.84 4.50 5.81 6.70 6.32 6.56 8.51 8.73 6.93 6.10
P/FCF ratio
0.00 49.30 20.76 20.90 32.12 56.74 19.42 53.50 69.98 53.62
P/Operating CF
47.79 63.22 67.96 477.74 66.55 80.42 39.07 89.82 42.42 77.38
Beneish M-Score
(2.46) (2.62) (2.73) (2.56) (2.78) (2.38) (2.68) (2.25) (1.97) (2.59)
Dividend Safety Score
— — — — — — — — — 74
P/B ratio
3.50 2.76 3.32 3.25 4.30 3.68 3.36 3.66 2.78 2.84
EV/Sales
3.30 2.67 3.11 2.86 3.90 3.21 2.96 3.45 2.85 3.19
EV/EBITDA
18.76 16.05 14.48 11.04 16.20 16.67 10.43 11.68 10.41 15.04
EV/FCF
(23.96) 53.45 21.36 20.70 31.88 55.73 18.18 50.29 69.10 53.09
Current Ratio
1.18 1.57 1.92 1.79 1.78 1.93 2.41 2.58 1.92 1.80
Net Debt/EBITDA
1.24 1.25 0.40 (0.10) (0.12) (0.30) (0.71) (0.75) (0.13) (0.15)
Debt/Equity
0.40 0.40 0.27 0.14 0.18 0.18 0.06 0.07 0.14 0.20
ROE
9.66% 7.83% 13.70% 12.69% 10.68% 12.76% 20.60% 21.63% 18.13% 11.40%
ROA
5.70% 4.41% 8.09% 8.17% 7.03% 8.30% 14.09% 15.60% 12.72% 7.63%
ROIC
5.45% 4.78% 8.51% 13.64% 12.25% 10.36% 19.68% 19.31% 13.82% 8.55%
Return on Tangible Assets
16.64% 10.05% 17.27% 17.78% 14.15% 15.73% 24.00% 24.32% 26.05% 17.09%
Average Days of Receivables
98.69 104.43 94.49 105.12 95.54 113.66 107.60 104.92 101.33 110.01
Earnings Yield
2.71% 2.84% 3.97% 4.06% 2.32% 3.35% 5.85% 5.46% 5.00% 3.88%
Free Cash Flow Yield
(4.47%) 2.03% 4.82% 4.78% 3.11% 1.76% 5.15% 1.87% 1.43% 1.86%
Free Cash Flow per Share
(0.36) 0.13 0.39 0.39 0.38 0.20 0.59 0.28 0.19 0.26
Book value per Share
2.30 2.34 2.44 2.48 2.85 3.03 3.38 4.05 4.74 4.87
Free Cash Flow
(299.00) 109.00 324.00 320.00 317.00 163.00 487.00 230.00 157.00 215.00
EV/EBIT
34.45 31.84 22.91 15.23 22.51 23.35 12.74 14.24 12.88 21.18
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026